Nutex Health Inc. (NUTX)
| Market Cap | 869.73M +37.2% |
| Revenue (ttm) | 879.95M +41.0% |
| Net Income | 96.38M +30.8% |
| EPS | 13.86 +8.7% |
| Shares Out | 6.88M |
| PE Ratio | 9.12 |
| Forward PE | 5.91 |
| Dividend | n/a |
| Ex-Dividend Date | n/a |
| Volume | 87,208 |
| Open | 123.36 |
| Previous Close | 124.70 |
| Day's Range | 120.55 - 127.00 |
| 52-Week Range | 77.21 - 193.07 |
| Beta | 2.07 |
| Analysts | Strong Buy |
| Price Target | 235.67 (+86.46%) |
| Earnings Date | Apr 30, 2026 |
About NUTX
Nutex Health Inc. operates as a healthcare services and operations company in the United States. It operates through three segments: Hospital, Population Health Management (PHM), and Real Estate. The Hospital segment develops and operates a network of micro hospitals, specialty hospitals, and hospital outpatient departments that offer healthcare services, including emergency room care, inpatient care, and behavioural health. It also provides imaging services, such as CT scan, X-ray, MRI, ultrasound, etc.; laboratory services; and onsite inpatie... [Read more]
Financial Performance
In 2025, Nutex Health's revenue was $875.26 million, an increase of 82.36% compared to the previous year's $479.95 million. Earnings were $70.79 million, an increase of 35.88%.
Financial StatementsAnalyst Summary
According to 3 analysts, the average rating for NUTX stock is "Strong Buy." The 12-month stock price target is $235.67, which is an increase of 86.46% from the latest price.
News
Nutex Health Slides: Corporate presentation
Nutex Health has posted slides in relation to its latest quarterly earnings report, which was published on May 4, 2026.
Nutex Health Earnings Call Transcript: Q1 2026
Revenue and net income grew year-over-year, while adjusted EBITDA declined due to arbitration cost timing. Cash flow and liquidity remain strong, with new hospital openings and direct development initiatives supporting future growth. Legislative and payer dynamics continue to influence reimbursement.
Nutex Health Earnings release: Q1 2026
Nutex Health released its Q1 2026 earnings on May 1, 2026, summarizing the period's financial results.
Nutex Health Quarterly report: Q1 2026
Nutex Health has published its Q1 2026 quarterly earnings report on May 1, 2026.
Nutex Health reports Q1 EPS $6.52 vs. $3.33 last year
Reports Q1 revenue $216.49M, consensus $227.8M. “The 2026 year has started out strong producing solid revenue of $216.5 million, net income attributable to Nutex of $46.8 million, diluted EPS of…
NUTEX HEALTH REPORTS FIRST QUARTER 2026 FINANCIAL RESULTS
HOUSTON, April 30, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), today announced financial results for the three months ended March 31, 2026. Nutex Health is...
Nutex Health Transcript: AGM 2026
The meeting covered director elections, executive compensation, and auditor ratification, with all proposals approved by the required majority. Voting results will be reported on Form 8-K within four business days.
Nutex Health Schedules 2026 First Quarter Financial Results Release and Conference Call
HOUSTON, April 22, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatie...
Nutex Health Proxy statement: Proxy Filing
Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Nutex Health Proxy statement: Proxy Filing
Nutex Health filed a proxy statement on March 13, 2026, providing details for shareholder voting and corporate governance matters.
Nutex Health Earnings Call Transcript: Q4 2025
Revenue grew 82% to $875.3M in 2025, with net income up to $70.8M and adjusted EBITDA rising 152.6%. Despite a one-time $55M Q4 revenue reduction from arbitration true-up, cash flow and patient volumes remained strong, supporting continued expansion and high patient satisfaction.
Nutex Health Earnings release: Q4 2025
Nutex Health released its Q4 2025 earnings on March 6, 2026, summarizing the period's financial results.
Nutex Health Annual report: Q4 2025
Nutex Health has published its Q4 2025 annual report on March 6, 2026.
Morning Movers: Nutex Health sinks after fourth quarter results
Futures are lower this morning with investors continuing to price the macro and geopolitical shock stemming from the rapidly escalating conflict involving Iran and its implications for global energy s...
Nutex Health reports Q4 revenue $151.7M vs. $257.6M last year
Net income attributable to Nutex Health (NUTX) for the three months ended December 31, 2025 was $11.8M as compared to net income attributable to Nutex Health of $61.6M for the…
Nutex Health reports Q4 EPS $10.48 vs. last year
Reports Q4 revenue $151.7M, consensus $258.82M. The company attributes the $105.9M revenue decrease primarily to two items: a one-time $55.0M cumulative true-up of arbitration claims determined inelig...
Nutex Health reports 2025 EPS $10.48 vs. $9.69 in 2024
18:42 EST Nutex Health (NUTX) reports 2025 EPS $10.48 vs. $9.69 in 2024
Nutex Health authorizes $25M share repurchase program
Nutex Health (NUTX) has authorized a second stock repurchase program of up to $25.0M of the company’s common stock over the next six months. The share repurchase program authorization does…
NUTEX HEALTH REPORTS 2025 FINANCIAL RESULTS AND ANNOUNCES SECOND STOCK REPURCHASE PROGRAM
FULL YEAR 2025 HIGHLIGHTS: Total revenue of $875.3 million for the year 2025 versus $479.9 million for the year 2024, an increase of 82.4% Net income attributable to Nutex Health of $70.8 million for ...
Nutex Health Slides: Company presentation
Nutex Health has posted slides in relation to its latest quarterly earnings report, which was published on March 5, 2026.
Nutex Health Schedules 2025 Fourth Quarter and Year-End Financial Results and Earnings Conference Call
HOUSTON, Feb. 25, 2026 /PRNewswire/ -- Nutex Health, Inc. (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro hospitals and hospital outpatien...
NUTEX HEALTH RE-OPENS BAYOU CITY ER & HOSPITAL IN HOUSTON
HOUSTON, Jan. 12, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 27 state-of-the-art micro...
NUTEX HEALTH TO ATTEND AND PRESENT AT THE 2026 J.P. MORGAN HEALTHCARE CONFERENCE IN JANUARY IN SAN FRANCISCO
HOUSTON, Jan. 5, 2026 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micro ...
NUTEX HEALTH OPENS ARCHVIEW ER & HOSPITAL IN ST. LOUIS
HOUSTON , Dec. 22, 2025 /PRNewswire/ -- Nutex Health Inc. ("Nutex Health" or the "Company") (NASDAQ: NUTX), a physician-led, integrated healthcare delivery system comprised of 26 state-of-the-art micr...
Nutex Health extends stock repurchase program
Nutex Health (NUTX) announced that its board of directors has approved an extension of the previously authorized stock repurchase program. The program, originally announced on August 14, authorized th...